Trial Profile
Double-Blind, Randomized, Two Period Crossover Comparison of the Cognitive and Behavioral Effects of Eslicarbazepine Acetate and Carbamazepine in Healthy Adults
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Aug 2023
Price :
$35
*
At a glance
- Drugs Carbamazepine (Primary) ; Eslicarbazepine acetate (Primary)
- Indications Epilepsy; Migraine; Partial epilepsies
- Focus Therapeutic Use
- 26 Jun 2018 Status changed from recruiting to completed.
- 29 Sep 2016 New trial record